IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

April 9-12, 2018

International Oncolytic Virus Conference

Stephen J. Russell, M.D., Ph.D., Vyriad CEO, has been invited to Chair, Innate and collateral adaptive tumor immunity. Dr. Russell will also participate in Steve Russell (Once should be enough!) vs. Alan Melcher (Repeat dosing is crucial!) Kah-Whye Peng, Ph.D., Vyriad Chief Technology Officer, has been invited to Chair, Translation, imaging and clinical breakthroughs. Dr. Peng will be presenting: Oncolytic virus encoding IFNbeta: optimizing therapeutic index.

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com